display

The Bavarian Prime Minister Markus Söder (CSU) has accused the European Union of making mistakes in the fight against the corona pandemic.

The vaccine was ordered too late and only a few manufacturers were used, said Söder on Friday in the ZDF “Morgenmagazin”.

The result has so far been unsatisfactory.

“The operational responsibility lay in Europe,” Söder stated.

The fundamental importance was underestimated.

Now, a few weeks after the start of vaccination, one is at a point in this country where the ordered quantities do not arrive and vaccinations are therefore postponed.

“It's a very, very uncertain situation for such an important topic.

And I think it was underestimated in some places in Germany at the beginning, ”said Söder.

Now what is needed is “maximum transparency” when dealing with problems.

Söder welcomed the federal and state vaccination summit on Monday.

Now it is about getting more vaccine faster.

"It cannot be that such a large continent, which is so economically strong and has so many large pharmaceutical companies, cannot make more production possible than just one plant that is about to start up in Marburg." said Söder.

display

The Prime Minister was skeptical about easing the corona restrictions, which are limited to mid-February.

“I am not convinced that everything will be canceled on the 14th.

I don't think it's the time for great relaxation. ”Mutation and premature relaxation are“ a toxic combination ”.

Spahn is in the mood for "tough weeks"

The Federal Health Minister Jens Spahn (CDU) sees a similar view, who on Friday continued to get the population in the mood for “hard weeks”.

Nevertheless, the vaccination campaign was "on the right track," stressed Spahn.

He reiterated the goal that all residents of nursing homes should receive a vaccination offer by mid-February, and all over 80 year olds by the end of March.

The minister welcomed the approval of vaccine manufacturer Biontech's new production facility in Marburg on Thursday.

He also viewed AstraZeneca's promise to deliver more vaccine doses to the EU than previously announced as positive.

"That creates trust," emphasized Spahn.

display

He reiterated the expectation that the approval of AstraZeneca's vaccine by the European Medicines Agency (EMA) should be restricted to the elderly.

To include these, "the data situation is not sufficient," said the minister.

The EMA approval recommendation for the AstrZzeneca product is expected this Friday.

The drop in the so-called incidence value of new infections per 100,000 inhabitants in seven days below the threshold of 100 was assessed by Spahn as "initially encouraging".

This shows that the current restrictions are working.

However, Spahn added: "That is not enough".